- Home
- BLRX
BLRX
BioLineRx Ltd.
as 07-26-2024 4:00pm EST
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
| Founded: | 2003 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 68.0M | IPO Year: | 2011 |
| Target Price: | $21.00 | AVG Volume (30 days): | 368.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.51 - $2.53 | Next Earning Date: | 08-28-2024 |
| Revenue: | $11,655,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BioLineRx Ltd. News
BLRX Breaking Stock News: Dive into BLRX Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
2 months ago
BLRX: First Quarter 2024 Results
CNW Group
2 months ago
Start Proud Opens the Market
Associated Press Finance
2 months ago
Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it
Business Wire
2 months ago
Form 8.3 - Darktrace plc
Investor's Business Daily
2 months ago
Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives
Yahoo Finance Video
2 months ago
May jobs reports signals Fed's soft landing: US Labor Secretary
Business Wire
2 months ago
NICE to Webcast Financial Analyst and Investor Day at Interactions 2024
PR Newswire
2 months ago
Notification of major holding in Kindred Group plc
Compare BLRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLRX BioLineRx Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.